Ohio Public Employees Retirement System (OPERS)’s Spero Therapeutics SPRO Stock Holding History
Bought
Maintained
Sold
Other funds holding SPRO
ACM
AVAI
BI
RSCM
AI
NHAS
AG
AIC
Ohio Public Employees Retirement System (OPERS)'s SPRO Position: Q3 2020 in Review
Ohio Public Employees Retirement System (OPERS) sold out of Spero Therapeutics (SPRO) in Q3 2020, closing a stake of 11,630 shares — an estimated $157K sold.
Ohio Public Employees Retirement System (OPERS) first reported a position in SPRO in Q4 2019 and held it in 3 quarters. The position peaked at $157K in Q2 2020. 78 funds tracked by Wall St. Rank hold SPRO as of Q3 2020.
- Ohio Public Employees Retirement System (OPERS) reported no remaining Spero Therapeutics position as of Q3 2020 after selling out during the quarter.
- Ohio Public Employees Retirement System (OPERS) sold 11,630 Spero Therapeutics shares in Q3 2020, an estimated $157K.
- Ohio Public Employees Retirement System (OPERS) first reported a position in Spero Therapeutics in Q4 2019 and held it in 3 quarters.
- Ohio Public Employees Retirement System (OPERS)'s Spero Therapeutics position peaked at $157K in Q2 2020.
- 78 funds tracked by Wall St. Rank held Spero Therapeutics as of Q3 2020.
Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q3 2020, filed 16 Nov 2020.